The IMGA Futurum Tech Fund is a specialised Venture Capital Fund (FCR) regulated by the CMVM and domiciled in Portugal. The fund targets high-growth technology companies in the "Atlantic Corridor" through a strategic partnership between IM Gestão de Ativos (IMGA), Portugal's largest independent asset manager, and Futurum Capital. It offers investors a Golden Visa–eligible route (Capital Transfer) with zero real estate exposure, focusing on scalable startups bridging the Brazilian and Portuguese ecosystems.
The Institutional Powerhouse The IMGA Futurum Tech Fund represents a convergence of institutional rigour and entrepreneurial agility. It is managed by IM Gestão de Ativos (IMGA), the undisputed leader in Portugal’s independent asset management sector. With over 30 years of history and billions in assets under management, IMGA provides the robust governance, compliance infrastructure, and reporting standards that international investors require. This institutional bedrock is paired with the specialised expertise of Futurum Capital, a venture capital firm with a strong footprint in São Paulo, Lisbon, Miami, and Abu Dhabi, known for identifying disruptive technology in the Lusophone world.
The "Atlantic Bridge" Thesis This fund operates on a high-conviction investment thesis: the Atlantic Bridge. Portugal has rapidly evolved into the primary gateway for Latin American—specifically Brazilian—technology companies seeking to enter the European market. The IMGA Futurum Tech Fund is in a unique position to capitalise on this value arbitrage. By finding startups that are already successful in the large Brazilian market and helping them grow through Portugal, the fund speeds up their increase in value from emerging market standards to European levels.
Strategic Focus: Future Tech & Life Sciences Moving beyond generalist strategies, the fund concentrates on "Deep Tech" sectors where domain expertise creates defensible moats. The portfolio is constructed around two primary pillars:
Future Tech: Investing in B2B solutions across Artificial Intelligence (AI), Fintech, Cybersecurity, and Clean Tech that solve systemic inefficiencies.
Life Sciences: Targeting high-impact health technology and biotech ventures that capitalise on Portugal’s growing reputation as a European R&D hub. The investment scope focuses on seed-to-series B rounds, targeting companies that have moved beyond the "idea phase" and are ready for rapid scaling and internationalisation.
Operational Value & Compliance Unlike passive capital vehicles, the partnership employs an active management style. Futurum Capital leverages its global network to open doors in the Americas and the Middle East, ensuring portfolio companies have a clear path to exit. For the investor, the fund is structured as a Fundo de Capital de Risco (FCR), fully compliant with the post-2023 Portugal Golden Visa regulations. It strictly avoids real estate, mitigating sector-specific risks while fulfilling the "Capital Transfer" requirement of €500,000.